CONTENT VALIDATION AND
DISCLOSURES
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and
state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers
of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of
interest resolution process. In addition, all activity content is reviewed by both a member of the RTP
scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of
studies referenced and patient care recommendations.
FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts
of interest, which have been resolved through a conflict of interest resolution process: Dr Berlin — Advisory Committee: Amgen Inc; Consulting Agreements: AstraZeneca Pharmaceuticals LP,
Bayer Pharmaceuticals Corporation, Bristol-Myers Squibb Company, Genentech BioOncology,
ImClone Systems Incorporated, Pfizer Inc, Sanofi-Aventis; Data and Safety Monitoring Committee: Pfizer Inc; Paid Speaker: Bayer Pharmaceuticals Corporation, Genentech BioOncology.
Dr Ellis — Consulting Agreements: Genentech BioOncology, ImClone Systems Incorporated; Paid
Research: Amgen Inc, ImClone Systems Incorporated, Sanofi-Aventis. Dr Fuchs — Advisory Committee: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Genentech BioOncology, ImClone
Systems Incorporated, Roche Laboratories Inc, Sanofi-Aventis; Speakers Bureau: Genentech BioOncology.
Dr Goldberg — Consulting Agreements: Amgen Inc, AstraZeneca Pharmaceuticals LP, Bristol-Myers
Squibb Company, Genentech BioOncology, Genomic Health Inc, ImClone Systems Incorporated, Novartis
Pharmaceuticals Corporation, Pfizer Inc, Poniard Pharmaceuticals, Sanofi-Aventis. Dr Grothey — Advisory
Committee: Genentech BioOncology, Genomic Health Inc, Pfizer Inc, Roche Laboratories Inc, Sanofi-
Aventis; Consulting Agreements: Amgen Inc, Bayer Pharmaceuticals Corporation, Bristol-Myers Squibb
Company, Genentech BioOncology, Roche Laboratories Inc. Dr Haller — Advisory Committee: Abraxis
BioScience, Amgen Inc, Genentech BioOncology, Sanofi-Aventis; Consulting Agreement: Sanofi-Aventis. Dr Hurwitz — Consulting Agreements: Amgen Inc, Bristol-Myers Squibb Company, Genentech
BioOncology, Roche Laboratories Inc; Paid Research: Amgen Inc, Bristol-Myers Squibb Company,
Cephalon Inc, Genentech BioOncology, GlaxoSmithKline, ImClone Systems Incorporated, Novartis
Pharmaceuticals Corporation, Pfizer Inc, Pharmion Corporation, Sanofi-Aventis. Dr Meropol —
Consulting Agreements: Amgen Inc, Genentech BioOncology, Genomic Health Inc, Pfizer Inc, Saladax
Biomedical, Sanofi-Aventis, Zealand Pharma A/S; Lecture: Biogen Idec; Stock Ownership: Saladax
Biomedical. Dr Venook — Advisory Committee: Amgen Inc, ImClone Systems Incorporated; Grant
Funding: Genentech BioOncology; Paid Research: Novartis Pharmaceuticals Corporation, Pfizer Inc.
MODERATOR — Dr Love does not receive any direct remuneration from industry. Research To Practice
receives funds in the form of educational grants to develop CME activities from the following commercial
interests: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Aureon Laboratories Inc, Bayer
Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Bristol-Myers Squibb Company,
Celgene Corporation, Eisai Inc, Eli Lilly and Company, Genentech BioOncology, Genomic Health Inc,
GlaxoSmithKline, ImClone Systems Incorporated, Merck and Company Inc, Millennium Pharmaceuticals
Inc, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, OSI Oncology, Pfizer Inc, Roche
Laboratories Inc, Sanofi-Aventis, Synta Pharmaceuticals Corp and Wyeth.
RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers
for Research To Practice have no real or apparent conflicts of interest to disclose.
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by
the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled
indications. Please refer to the official prescribing information for each product for discussion of approved indications,
contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those
of the publisher or grantors.
